Tech stocks are among the stocks that have underperformed this year. This also includes high-growth health-tech stocks like Doximity (DOCS), even after those two years of the COVID-19 pandemic, which ...

Update 10/31: A previous version of this story’s headline referred to Doximity as a startup. It is, in fact, not a startup but a publicly-traded company. At its core, digital health platform Doximity ...

Doximity is the most used healthcare social platform in the US, with over 2 million users. Doximity’s business model represents both its biggest strength and threat being excessively focused on a ...

Doximity (DOCS) closed at $71.03 in the latest trading session, marking a +1.1% move from the prior day. The stock outperformed the S&P 500, which registered a daily loss of 0.05%. Meanwhile, the Dow ...

Doximity, which is like a LinkedIn for physicians that lets them share patient data in a HIPAA-compliant way, said that it’s now reaching about 30 percent of doctors in the country. They’ve got about ...